Why is Indrayani Biotec falling/rising?
As of 15-Oct, Indrayani Biotech Ltd's stock price is 15.52, up 5.08% with strong recent performance and increased investor interest. However, it has significant long-term declines, raising concerns about its viability despite recent positive trends.
As of 15-Oct, Indrayani Biotech Ltd's stock price is currently at 15.52, reflecting an increase of 0.75 or 5.08%. The stock has shown strong performance recently, gaining for the last four consecutive days and achieving a remarkable 29.01% return during this period. Additionally, the stock's current price is higher than its 5-day, 20-day, 50-day, and 100-day moving averages, indicating positive momentum. The floriculture sector has also seen gains of 5.05%, which may contribute to the stock's upward movement. Furthermore, there has been a notable increase in investor participation, with delivery volume rising by 55.96% compared to the 5-day average, suggesting growing interest in the stock.In the broader market context, Indrayani Biotech's short-term performance significantly outpaces the benchmark, with a 1-week return of +25.67% compared to the Sensex's +1.02%. This indicates that the stock is gaining traction relative to the overall market. However, it is important to note that the stock has experienced substantial declines over longer periods, with a year-to-date decrease of 57.34% and a one-year decline of 60.74%, which may raise concerns among investors about its long-term viability. Despite these challenges, the recent positive trends in both the stock's performance and sector activity suggest a potential turnaround in investor sentiment.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
